Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -60.82% is 258% below its 5-year average of -16.99%, near the low end of its 5-year range (-60.82%–0.06%).
As of the fiscal period ended Tuesday, June 30, 2026. 136.00% below its 12-month average of -25.77%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -60.82%.
RETURN ON EQUITY (ROE)
-60.82%
RETURN ON EQUITY (ROE) AVG TTM
-25.77%
RETURN ON EQUITY (ROE) AVG 3Y
-24.25%
RETURN ON EQUITY (ROE) AVG 5Y
-16.99%
RETURN ON EQUITY (ROE) AVG 10Y
-9.11%
RETURN ON EQUITY (ROE) AVG 15Y
-5.54%
RETURN ON EQUITY (ROE) AVG 20Y
-2.20%
CURRENT VS TTM AVG
-136.00%
CURRENT VS 3Y AVG
-150.80%
CURRENT VS 5Y AVG
-258.07%
CURRENT VS 10Y AVG
-567.74%
CURRENT VS 15Y AVG
-997.81%
CURRENT VS 20Y AVG
-2660.22%
SECTOR MEDIAN · HEALTHCARE
-38.55%
median of 491 covered companies
CURRENT VS SECTOR MEDIAN
-57.78%
vs the sector median at left
Cumberland Pharmaceuticals Inc.
Market Cap
$106.38M
Return on Equity (ROE)
-60.82%
TTM Avg
-25.77%
3Y Avg
-24.25%
5Y Avg
-16.99%
Market Cap
$106.13M
Return on Equity (ROE)
-99.67%
TTM Avg
-40.73%
3Y Avg
98.81%
5Y Avg
13.93%
Market Cap
$107.84M
Return on Equity (ROE)
-5.10%
TTM Avg
-4.24%
3Y Avg
-6.16%
5Y Avg
0.09%
Market Cap
$104.81M
Return on Equity (ROE)
-116.28%
TTM Avg
-71.19%
3Y Avg
-41.66%
5Y Avg
-29.50%
Market Cap
$108.59M
Return on Equity (ROE)
-44.29%
TTM Avg
-31.86%
3Y Avg
-53.29%
5Y Avg
-49.85%
Market Cap
$109.49M
Return on Equity (ROE)
-80.97%
TTM Avg
-121.11%
3Y Avg
-93.50%
5Y Avg
-70.15%
Market Cap
$102.35M
Return on Equity (ROE)
23.96%
TTM Avg
-4.38%
3Y Avg
-11.56%
5Y Avg
6.84%
Market Cap
$110.88M
Return on Equity (ROE)
-87.45%
TTM Avg
455.42%
3Y Avg
120.34%
5Y Avg
63.42%
Market Cap
$111.33M
Return on Equity (ROE)
-93.44%
TTM Avg
-8.16%
3Y Avg
13.24%
5Y Avg
13.24%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cumberland Pharmaceuticals Inc. (CPIX) | $106.38M | -60.82% | -25.77% | -24.25% | -16.99% |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP)vs › | $106.13M | -99.67% | -40.73% | 98.81% | 13.93% |
| BGM Group Ltd. (BGM)vs › | $107.84M | -5.10% | -4.24% | -6.16% | 0.09% |
| Definitive Healthcare Corp. (DH)vs › | $104.81M | -116.28% | -71.19% | -41.66% | -29.50% |
| Black Diamond Therapeutics, Inc. (BDTX)vs › | $108.59M | -44.29% | -31.86% | -53.29% | -49.85% |
| Apyx Medical Corporation (APYX)vs › | $109.49M | -80.97% | -121.11% | -93.50% | -70.15% |
| The Joint Corp. (JYNT)vs › | $102.35M | 23.96% | -4.38% | -11.56% | 6.84% |
| Immunic, Inc. (IMUX)vs › | $110.88M | -87.45% | 455.42% | 120.34% | 63.42% |
| Aardvark Therapeutics, Inc. Common Stock (AARD)vs › | $111.33M | -93.44% | -8.16% | 13.24% | 13.24% |
| Foghorn Therapeutics Inc. (FHTX)vs › | $112.14M | N/A | 129.36% | -24207.46% | -16163.58% |
ROE
-60.8%
ROA
-16.9%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | -60.82% |
| 2026-03-31 | -33.42% |
| 2025-12-31 | -11.40% |
| 2025-09-30 | -12.74% |
| 2025-06-30 | -10.47% |
| 2025-03-31 | -11.43% |
| 2024-12-31 | -28.35% |
| 2024-09-30 | -43.87% |
| 2024-06-30 | -39.38% |
| 2024-03-31 | -30.62% |
| 2023-12-31 | -21.21% |
| 2023-09-30 | -6.74% |
| 2023-06-30 | -4.80% |
| 2023-03-31 | -10.98% |
| 2022-12-31 | -15.36% |
| 2022-09-30 | -18.00% |
| 2022-06-30 | -19.32% |
| 2022-03-31 | -12.33% |
| 2021-12-31 | -8.19% |
| 2021-09-30 | -1.16% |
| 2021-06-30 | 0.06% |
| 2021-03-31 | -4.50% |
| 2020-12-31 | -7.11% |
| 2020-09-30 | -7.13% |
| 2020-06-30 | -10.08% |
| 2020-03-31 | -9.06% |
| 2019-12-31 | -6.92% |
| 2019-09-30 | -9.27% |
| 2019-06-30 | -8.30% |
| 2019-03-31 | -8.40% |
| 2018-12-31 | -12.47% |
| 2018-09-30 | -9.52% |
| 2018-06-30 | -7.75% |
| 2018-03-31 | -14.87% |
| 2017-12-31 | -12.44% |
| 2017-09-30 | -12.18% |
| 2017-06-30 | -10.62% |
| 2017-03-31 | -2.72% |
| 2016-12-31 | -1.29% |
| 2016-09-30 | -0.06% |
| 2016-06-30 | -0.03% |
| 2016-03-31 | 0.57% |
| 2015-12-31 | 0.95% |
| 2015-09-30 | 1.61% |
| 2015-06-30 | 2.37% |
| 2015-03-31 | 2.75% |
| 2014-12-31 | 3.00% |
| 2014-09-30 | 0.31% |
| 2014-06-30 | -1.62% |
| 2014-03-31 | -3.38% |
| 2013-12-31 | -2.65% |
| 2013-09-30 | 1.48% |
| 2013-06-30 | 4.69% |
| 2013-03-31 | 7.37% |
| 2012-12-31 | 6.82% |
| 2012-09-30 | 5.93% |
| 2012-06-30 | 5.91% |
| 2012-03-31 | 6.54% |
| 2011-12-31 | 6.82% |
| 2011-09-30 | 6.68% |
| 2011-06-30 | 5.82% |
| 2011-03-31 | 3.64% |
| 2010-12-31 | 3.16% |
| 2010-09-30 | 2.56% |
| 2010-06-30 | 2.98% |
| 2010-03-31 | 2.98% |
| 2009-12-31 | 4.28% |
| 2009-09-30 | 5.53% |
| 2009-06-30 | 19.23% |
| 2009-03-31 | 24.85% |
| 2008-12-31 | 27.15% |
| 2008-09-30 | 21.22% |
| 2008-06-30 | 23.07% |
| 2008-03-31 | 25.78% |
| 2007-12-31 | 24.15% |
| 2007-09-30 | 42.41% |
| 2007-06-30 | 48.14% |
| 2007-03-31 | 52.03% |
| 2006-12-31 | 39.59% |
